Form 4: Hims & Hers Health, Inc. Executive Awarded Over 1 Million in Restricted Stock Units
SEC Form 4 Filing
Mohamed Elshenawy, Chief Technology Officer of Hims & Hers Health, Inc., was granted 1,036,339 Restricted Stock Units (RSUs) on May 12, 2025, vesting over a four-year period.
Summary
- Mohamed Elshenawy, the Chief Technology Officer of Hims & Hers Health, Inc., received 1,036,339 Restricted Stock Units (RSUs) on May 12, 2025.
- These RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU.
- The RSUs are subject to a four-year service-based vesting schedule, with 25% vesting on June 15, 2026.
- The remaining 75% of the RSUs will vest in substantially equal quarterly installments thereafter on March 15, June 15, September 15, and December 15.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating confidence in the company's future. The sentiment is neutral to positive.
Positives
- The grant of RSUs aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.
Industry Context
Equity compensation is a common practice in the technology and healthcare industries to attract and retain top talent. The size and vesting schedule of the RSU grant are typical for executive compensation packages.
Comparison to Industry Standards
- Similar companies in the telehealth space, such as Teladoc Health and Amwell, also utilize equity compensation to incentivize their executives.
- RSU grants are a standard component of compensation packages for CTOs in publicly traded companies, often vesting over a 3-4 year period to align with long-term company performance.
Stakeholder Impact
- Shareholders may view the RSU grant as a positive sign, aligning executive interests with company performance.
- Employees may see this as a positive sign of investment in leadership.
Key Dates
| Date | Description |
|---|---|
| 05/12/2025 | Date of the transaction (grant of RSUs) |
| 05/14/2025 | Date of the Form 4 filing |
| 06/15/2026 | Date when 25% of the RSUs vest |
Keywords
Restricted Stock Units, RSUs, Hims & Hers Health, Mohamed Elshenawy, Chief Technology Officer, Equity Compensation, Vesting, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.